文献速递腹部MR

T2 mapping评估非酒精性脂肪性肝病肝脂肪变、炎症和纤维化的可行性初步研究

The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study.
PubMed 文献 · Clin Radiol · 2021-07-12

结果显示肝T2值与组织学脂肪变百分比和分级均呈良好正相关(r=0.780,rs=0.779),明确NASH患者T2值显著高于非NASH者(69±7.37 vs 61.73±5.99 ms,p=0.016)。校正肝脂肪变后T2值与纤维化分期呈密切负相关(r=-0.536,p=0.012)。

要点

  • 肝T2值与组织学脂肪变程度呈良好正相关,可用于无创定量肝脂肪变。
  • 明确NASH患者肝T2值显著高于非NASH患者,提示T2值可能反映炎症活动。
  • 校正脂肪变后T2值与纤维化分期呈负相关,纤维化越重T2值越低。

核心结论

  • T2 mapping可用于定量肝脂肪变,其T2弛豫值与组织学确定的脂肪变程度密切相关。
  • 明确NASH患者肝T2值升高,且校正肝脂肪变后T2值与纤维化分期呈负相关。
  • T2 mapping可能成为NAFLD疾病评估和预后判断的有用临床工具。

研究设计与样本

  • 所有患者采用快速自旋回波多回波序列(8个回波)进行T2测量。
  • 以组织学活检作为参考标准,评估肝T2值与脂肪变、炎症及纤维化的相关性。

诊断标准与关键数值

  • 肝T2值与组织学脂肪变百分比呈良好正相关(r=0.780,p<0.001),与脂肪变分级亦呈良好正相关(rs=0.779,p<0.001)。
  • 明确NASH患者平均肝T2值显著高于非NASH患者(69±7.37 vs 61.73±5.99 ms,p=0.016)。
  • 肝T2值与NAFLD活动度评分(NAS)呈显著正相关(rs=0.443,p=0.034),但校正肝脂肪变和纤维化后相关性消失(r=0.131,p=0.572)。
  • 校正肝脂肪变后,肝T2值与纤维化分期呈密切负相关(r=-0.536,p=0.012)。

临床应用与阅片要点

  • 阅片时可关注肝T2值升高,提示脂肪变程度较重或存在明确NASH。
  • 评估肝T2值时需考虑纤维化的影响,纤维化分期较高者T2值可能偏低。
  • T2值与NAS的相关性受脂肪变和纤维化混杂,解读时应结合组织学或影像其他指标综合判断。

局限性

  • 单中心、连续纳入设计,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To determine the feasibility of magnetic resonance imaging T2 mapping in the quantification of liver steatosis in patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD), and to assess the effect of inflammation and fibrosis on T2 values of the liver.

MATERIAL AND METHODS: Twenty-three consecutive patients with biopsy-proven NAFLD who underwent T2 mapping between December 2013 and September 2014 were included in this study. All patients underwent fast spin echo multi-echo sequence with eight echoes for T2 measurements.

RESULTS: The mean liver T2 value and percentage of histological steatosis was 64.9 ± 7.4 ms and 46.5 ± 27.6%, respectively. There was a good correlation between the liver T2 value and histology-determined steatosis (r = 0.780, p<0.001) and grade of steatosis (rs = 0.779, p<0.001). The mean T2 value in patients with definitive non-alcoholic steatohepatitis (NASH) was significantly higher in comparison with patients without NASH (69 ± 7.37 versus 61.73 ± 5.99 ms, p=0.016). The correlation between T2 value and NAFLD activity score (NAS) was significant (rs = 0.443, p=0.034); however, the correlation disappeared after adjustment for hepatic steatosis and fibrosis (r=0.131, p=0.572). There was a close inverse correlation between T2 value and fibrosis stage after adjusting for hepatic steatosis (r=-0.536, p=0.012).

CONCLUSION: T2 mapping can be used for quantification of hepatic steatosis, as there is a close correlation between T2 relaxation values and histology-determined steatosis. Patients with definite NASH have increased T2 values and there is an inverse correlation between the T2 value and fibrosis stage of the liver. T2 mapping in NAFLD may be a useful clinical tool for disease assessment and prognostication.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Idilman IS, Celik A, Savas B, et al. The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study. Clin Radiol. 2021. PMID: 34266657. doi:10.1016/j.crad.2021.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。